Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Go back to Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
(NASDAQ: KRYS) Delayed: 365.74 +1.90 (0.52%)
Previous Close $363.84    52 Week High
Open $366.00    52 Week Low
Day High $373.19    P/E N/A 
Day Low $360.86    EPS
Volume 119,495